Clinical Trials Directory

Trials / Completed

CompletedNCT00646815

Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to further characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic-intramyocellular lipids in patients with growth hormone deficiency (GHD).

Conditions

Interventions

TypeNameDescription
DRUGgrowth hormone (genotropin)Dosage regulation will follow the local recommendations of GHD treatment

Timeline

Start date
2008-03-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2008-03-31
Last updated
2009-10-22

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00646815. Inclusion in this directory is not an endorsement.

Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency (NCT00646815) · Clinical Trials Directory